# Why Compounded Semaglutide Is Mixed With B12

By Ruth Calder, Enforcement Editor (https://glpwatchdog.org/authors/ruth-calder) | Published: 2026-08-14 | Updated: 2026-11-06

Canonical page: https://glpwatchdog.org/research/semaglutide-compounded-with-b12

> What is actually established about the B12 in compounded semaglutide, what is only claimed, and the questions to put to the pharmacy that mixed it.

## Key points

- FDA uses semaglutide plus B12 as its own example of a combination that may still be "essentially a copy" of an approved drug.
- No approved semaglutide injection contains vitamin B12. Ozempic's label lists four inactive ingredients, none of them a vitamin.
- The nausea explanation is the one most often given and the one with no trial behind it.
- The only published clinical dataset on semaglutide/cyanocobalamin had no semaglutide-alone arm, so it cannot credit the vitamin with anything.
- The legal exception is narrow: a documented prescriber finding for one identified patient, not a house formulation.

Cyanocobalamin is vitamin B12, the vitamin in [the B12 shots weight-loss clinics sell](https://glpwatchdog.org/research/hcg-and-lipotropic-weight-loss-shots), and it is in the vial because a compounder put it there. The approved semaglutide injection lists no vitamin among its ingredients at all.[7] Four claims about the pairing get made to buyers, and FDA has answered only one of them in writing.

## Read the label as two separate facts

A vial reading **semaglutide/cyanocobalamin** is telling you two things at once. The first is the second ingredient. The second, and the more consequential one, is that nobody manufactures that pairing under an approved application. A two-ingredient injection of this kind exists only because someone mixed it.

The comparison is easy to check. Section 11 of the Ozempic label lists semaglutide alongside disodium phosphate dihydrate, propylene glycol, phenol and water for injections. That is the whole list, and no form of vitamin B12 appears anywhere on it.[7]

## FDA has written about this exact pairing by name

FDA did not leave compounded GLP-1 combinations to be argued about in the abstract. It used semaglutide plus B12 as its own illustration when it set out how the “essentially a copy” restriction applies.[1]

> FDA may consider a compounded drug product that combines semaglutide API and another API, such as vitamin B12 (cyanocobalamin), to be essentially a copy…
>
> — FDA, compounder policy update, April 1, 2026

The sentence ends “…of a commercially available drug product,” and the agency then gave the two conditions that make that judgment bite: the compounded product is given by the same route as the products already on the market (both injectable), and the amounts of semaglutide and of B12 sit within 10 percent of the strengths of those respective products.[1] Adding a second ingredient, in other words, is not on its own a way out of the restriction.

There is a way out, and it is narrow. Federal law bars a compounder from preparing, regularly or in inordinate amounts, drug products that are essentially copies of a commercially available one, and it defines the phrase so as to exclude a product carrying **a change, made for an identified individual patient, which produces for that patient a significant difference, as determined by the prescribing practitioner**.[2] FDA restates the same requirement as a prescriber determination that is documented.[1] Every load-bearing word there is singular: one patient, one prescriber, one written finding. A formulation offered to everyone who fills out the same intake form is not what that sentence describes.

One threshold explains why the restriction rarely bites on a small pharmacy and always bites on a subscription program: FDA has said it does not intend to act on the copy restriction against a compounder filling **four or fewer prescriptions** of that product in a calendar month.[1]

## The four claims, side by side

*What buyers are told about the B12, and what is on the record*

| What is claimed | What is established |
| --- | --- |
| The B12 blunts the nausea | Not established. No approved semaglutide product carries it,[7] and the pharmacy academics who catalogued these formulations reported finding little justification for adding nutrients to an injectable GLP-1. The ingredient in their survey with an antiemetic rationale behind it was ondansetron, not B12 — and even there they wrote that evidence for giving it subcutaneously is lacking.[5] |
| The B12 does something for you that semaglutide alone would not | Untested. The one published clinical dataset on semaglutide/cyanocobalamin followed 94 people for three months with no group taking semaglutide by itself, so nothing in it can be attributed to the vitamin rather than the drug.[6] |
| The extra ingredient makes it a different product, not a copy | A real legal argument, and FDA has answered it directly using this pairing as the example: the combination may still be treated as essentially a copy.[1] The statutory exception turns on a documented prescriber finding of a significant difference for one identified patient, not on the ingredient list.[2] |
| It is just how everyone sells it | Closest to demonstrable, and the weakest reason to accept it. In a 2025 sweep of compounder websites, 48 percent of 33 semaglutide and tirzepatide products were combinations — cyanocobalamin, glycine, niacinamide, docusate or ondansetron.[5] Common is not the same as justified. |

## What the published record contains, and what it does not

Two papers touch the combination directly, and neither is a trial of it. The first, in *Annals of Pharmacotherapy* in 2026, is an editorial-classified survey by pharmacy researchers who searched compounder websites and catalogued what was for sale. Their assessment of the nutrient additives was blunt, and it is their assessment rather than a measured result: little justification for putting them there.[5]

The second is a retrospective look at 94 people at a commercial wellness studio who received weekly semaglutide/cyanocobalamin, titrated so that both components rose together (0.25 mg with 0.125 mg at the start, up to 2.4 mg with 0.24 mg). Average weight loss at three months was about 4 kg.[6] The number is real, but it says nothing about the B12, because there was no arm without it. A single-arm study of a two-ingredient product can never tell you which ingredient did the work.

> **Absence of evidence is doing real work here.** If the nausea claim were established, the trial establishing it would be the easiest thing in this article to link to. It is not in the sources below because it is not in the literature, and a claim that has been made for years without ever being tested is a finding of its own.

## The trade you are actually making

This is not an argument that a compounded vial is dangerous, and pharmacy compounding is an ordinary part of American medicine. The point is narrower. FDA does not review a compounded drug for safety, effectiveness or quality before it reaches a patient,[3] and that gap covers the entire preparation: the vitamin, the concentration and the semaglutide as one object, not only the active ingredient you recognize.

Concentration is where that becomes practical rather than theoretical. FDA has received multiple adverse event reports, some involving hospitalization, that may relate to dosing errors with compounded injectable semaglutide, arising from patients measuring and self-administering incorrect doses and in some cases from clinicians miscalculating them.[4] A vial that is not the approved product is a vial whose markings, strength and units you cannot check against an approved label.

> **Take any formulation question to the prescriber managing your dose.** If a second ingredient in your vial is new to you, or your dose is about to change, that conversation belongs with the clinician who wrote the prescription and the pharmacy that filled it, before anything about how you use it changes. This page sets out what is on the public record about the combination. It is not advice about your prescription.

## Four questions worth putting to the pharmacy

1. **What is the B12 strength in my vial, and does it scale when my semaglutide dose goes up?** In the one published dataset the two rose together at a fixed ratio.[6] Whether yours does is a question your pharmacy can answer in one line.
2. **Who determined that this formulation is a significant difference for me, and where is that documented?** This is the precise wording the exception rests on.[2] A program that treats it as a house recipe has not met it.
3. **Which pharmacy compounded it, and is it state-licensed?** FDA's instruction to anyone buying prescription medicine is to fill it at a state-licensed pharmacy, and a name you can look up is the whole point.[4] Where a seller will not name one, we say so in the [provider register](https://glpwatchdog.org/reviews).
4. **What is the concentration, and how many units is one dose?** Ask for it in the units printed on your syringe, not in milligrams alone. The reported dosing errors came from exactly this arithmetic.[4]

If the answer to any of these is a brand promise rather than a number or a name, that is the answer. Our [breakdown of which GLP-1s can still be lawfully compounded](https://glpwatchdog.org/research/which-glp1-can-be-compounded) covers the rest of the rule this sits inside, and the [price tracker](https://glpwatchdog.org/price-tracker) shows what the market is doing.

Where the B12 comes from also tells you who should answer. [Strive Pharmacy](https://glpwatchdog.org/reviews/strive-pharmacy), a 503A pharmacy in Arizona and Texas, makes its compounded semaglutide and tirzepatide with glycine and B12 and fills prescriptions only from outside clinicians, so its pharmacist is the one to ask. [Revive Meds](https://glpwatchdog.org/reviews/revive-meds) combines B12 with both drugs and fills through named 503A pharmacies, and [Gide Health](https://glpwatchdog.org/reviews/gide-health) names an Ohio compounding pharmacy and lists B12 or glycine as an optional addition to its semaglutide shot. [Leanefy](https://glpwatchdog.org/reviews/leanefy) names its partner compounding pharmacy, in Sandy Springs, Georgia, and prices its compounded tirzepatide with B12 by dose, from $268 per 4 weeks at 2.5 mg to $430 at 15 mg. [ZestRx](https://glpwatchdog.org/reviews/zestrx) names Strive Pharmacy as the pharmacy that fills its prescriptions, and its compounded tirzepatide is made with vitamin B3 (niacinamide) instead of B12. [HumeCare+](https://glpwatchdog.org/reviews/humecare) sells its compounded tirzepatide only as a combination with vitamin B12 and glycine, at $299 a month at its checkout, and does not name its pharmacy.

[Goldspan Health](https://glpwatchdog.org/reviews/goldspan-health) and [June Health](https://glpwatchdog.org/reviews/june-health) sell versions made with either B12 or glycine, and [Green Cap Health](https://glpwatchdog.org/reviews/green-cap-health) lists its compounded tirzepatide with B12. [Glam Health](https://glpwatchdog.org/reviews/glam-health) puts B12 in both of its starting plans but names no pharmacy, which leaves the questions with the prescriber. [Persona Doctors](https://glpwatchdog.org/reviews/persona-doctors) combines B12 with both compounded semaglutide and tirzepatide and names only “a licensed 503A/503B pharmacy.” [Mankind Health](https://glpwatchdog.org/reviews/mankind-health) sells its tirzepatide injection with B12 and does not name the pharmacy that fills it. [Sipra](https://glpwatchdog.org/reviews/sipra) blends B12 into its injections and says on its own site that the combination has not been studied in large trials, which is consistent with the published record above. [Skinny Me America](https://glpwatchdog.org/reviews/skinny-me-america) describes its Skinny Shots as custom-blended semaglutide with B6 and B12, but ties neither of its two shot levels to a dose. [Stone Health](https://glpwatchdog.org/reviews/stone-health) mixes in more than B12: its microdose products put semaglutide or tirzepatide in one injection with NAD+ and B12, with B12 and MIC, or with L-carnitine, at $179 every 4 weeks. B12 is sold without any GLP-1 as well: [System Labs](https://glpwatchdog.org/reviews/system-labs), whose catalog has no semaglutide or tirzepatide, sells a lipotropic MIC+B12 injection at $89 a month. Every seller that names B12 in a compounded semaglutide price is on our [semaglutide with B12 board](https://glpwatchdog.org/best/compounded-semaglutide/with-b12), with the price we read and its date.

Sometimes B12 is sold as an extra rather than built into the plan. [Elevate Health](https://glpwatchdog.org/reviews/elevate-health) lists NAD+ and B12 as add-ons beside its compounded semaglutide and tirzepatide. If you choose the B12, ask whether it comes mixed into the same vial or as its own product, because the answer decides whether the first question above applies to you. At [Blissful Wellness Integrative Medicine](https://glpwatchdog.org/reviews/blissful-wellness) the shots come with the program: its 4-week plan includes four B12 injections and a multivitamin, and its 8- and 12-week plans include lipotropic shots.

## Frequently asked questions

### Is the B12 in compounded semaglutide there for nausea?

That is the reason most often given, and it is not established. No approved semaglutide product contains vitamin B12, and no trial testing whether B12 reduces GLP-1 nausea appears in the literature. Pharmacy researchers who catalogued these combination products in 2026 wrote that they found little justification for adding nutrients; the additive in their survey with an antiemetic rationale was ondansetron, not B12.

### Does adding B12 make it legal to compound semaglutide?

Not by itself. FDA used semaglutide combined with vitamin B12 as its own example of a product it may still treat as essentially a copy of an approved one, where the route of administration is the same and both strengths fall within 10 percent of the products already on the market. The exception in federal law is a change made for an identified individual patient that the prescribing practitioner determines produces a significant difference for that patient. That is a documented, per-patient finding, not a standard recipe.

### Is semaglutide/cyanocobalamin the same thing as Ozempic or Wegovy?

No. It is a compounded preparation, which means FDA has not reviewed it for safety, effectiveness or quality before it reaches you. That review gap applies to the preparation as a whole, including the concentration in the vial, not only to the semaglutide in it. Telehealth companies claiming a compounded drug is the same as an approved one are on FDA's own list of consumer warning signs.

### Should I ask for a version without the B12?

That is a question for the prescriber managing your dose, not one this page can answer for you. Switching formulations changes concentration, and concentration is where the reported dosing errors come from. What you can reasonably ask for is the strength of each component, the concentration in units you can measure, and the name of the pharmacy that compounded it.

## References

1. U.S. Food and Drug Administration FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. FDA Drug Alerts and Statements. 2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize
2. United States Code 21 U.S.C. § 353a — Pharmacy compounding (subsections (b)(1)(D) and (b)(2)). Legal Information Institute, Cornell Law School. 2026. https://www.law.cornell.edu/uscode/text/21/353a
3. U.S. Food and Drug Administration Human Drug Compounding Laws. FDA Human Drug Compounding. 2024. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
4. U.S. Food and Drug Administration FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. FDA Drug Alerts and Statements. 2026. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
5. Belcourt J, Sapowadia A, White CM. Compounded Semaglutide and Tirzepatide Products Use Unique Formulations but Efficacy and Safety Largely Unknown. Ann Pharmacother 2026;60(9):902-906 (editorial). 2026. DOI: 10.1177/10600280261421979. https://doi.org/10.1177/10600280261421979
6. Chun E, Siojo A, Rivera D, et al. Weight loss and body composition after compounded semaglutide treatment in a real world setting. Diabetes Obes Metab 2025;27(3):1536-1543. 2025. DOI: 10.1111/dom.16162. https://doi.org/10.1111/dom.16162
7. Novo Nordisk Pharmaceutical Industries, LP OZEMPIC (semaglutide) injection, for subcutaneous use — prescribing information, section 11 Description. DailyMed, U.S. National Library of Medicine. 2026. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79

---

Cite as: GLP Watchdog, Ruth Calder, "Why Compounded Semaglutide Is Mixed With B12", published 2026-08-14, updated 2026-11-06. https://glpwatchdog.org/research/semaglutide-compounded-with-b12

Canonical HTML page: https://glpwatchdog.org/research/semaglutide-compounded-with-b12

Medical disclaimer: Nothing here is medical advice. We report on this subject; we do not treat anyone. Whether to begin a medication, supplement, or treatment, whether to adjust it, and whether to stop are questions for a clinician licensed to answer them, who knows your history.